Log Out

JP Stock MarketDetailed Quotes

4506 Sumitomo Pharma

Watchlist

572
+6+1.06%

20min DelayNoon Break Dec 27 11:30 JST

227.60BMarket Cap-0.72P/E (Static)

Sumitomo Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sumitomo Pharma Q2 2025 Earnings Date

Currency：JPYOct 30, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	85.91B	90.07B	+4.17B
Beat Est.	+11.65%	+17.05%	+4.85%
EPS	17.94	-121.23	-139.17
Miss Est.	+124.68%	-66.80%	-775.69%

Analyst Rating

Underperform

Nov 26, 2024

Sumitomo Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual

Estimate

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 87.217B--

Jan 31, 20252025/Q3-- / 90.567B--

Oct 30, 20242025/Q290.074B / 85.908B--

Jul 31, 20242025/Q190.675B / 82.622B--

May 14, 20242024/Q479.530B / 79.948B--

Unlock Free Earnings Estimates

Open Account

Sumitomo Pharma Earnings Reports

Sumitomo Pharma: Interim report.

Dec 19 01:19 ET

Sumitomo Pharma: Confirmation letter

Oct 31 22:30 ET

Sumitomo Pharma: Semi-Annual Report - 205th Term (2024/04/01 - 2025/03/31)

Oct 31 22:26 ET

Sumitomo Pharma: Interim report

Oct 30 02:42 ET

Read more

Top JP Stock Gainers

Symbol Price % Chg

Alpico Holdings

Branding Technology

See the daily top gainer.

Analysis

Analyst Rating

Updated: Nov 26, 2024

Underper form

Strong Buy
0.00%
Buy
0.00%
Hold
62.50%
Underperform
0.00%
Sell
37.50%

Price Target

No Data